ScinoPharm Taiwan, Ltd. Announces Change of Directors
July 05, 2018 at 11:08 am
Share
ScinoPharm Taiwan, Ltd. announced that it has replaced Ih-Jen Su Independent Director of the company and Li-Tzong Chen resume as Independent Director of the company. Effective date of the new member is June 5, 2018.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
SCINOPHARM TAIWAN, LTD. 
